Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels.
Amphiphiles
Ether lipid
Fluorescence
Glyco-glycerolipid
Ion channel
Liposome
SK3
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
01 Jan 2021
01 Jan 2021
Historique:
received:
22
06
2020
revised:
04
09
2020
accepted:
24
09
2020
pubmed:
14
10
2020
medline:
22
4
2021
entrez:
13
10
2020
Statut:
ppublish
Résumé
We report the synthesis of three bioactive pyrene-based fluorescent analogues of Ohmline which is the most efficient and selective inhibitor of SK3 ion channel. The interaction of these Ohmline-pyrene (OP1-3) with liposomes of different composition reveals that only OP2 and OP3 are readily integrated into liposomes. Fluorescence measurements indicate that, depending on their concentration, OP2 and OP3 exist either as monomer or as a mixture of monomer and excimers within the liposome bilayer. Among the three Ohmline Pyrene compounds (OP1-3) only OP2 is able to reduce SK3 currents and is the first efficient fluorescent modulator of SK3 channel as revealed by patch clamp measurements (- 71.3 ± 13.3% at 10 μM) and by its inhibition of SK3-dependent cancer cell migration at (-32.5% ± 4.8% at 1 μM). We also report the first fluorescence study on living breast cancer cells (MDA-MB-231) showing that OP2 is rapidly integrated in bio-membranes followed by cell internalization.
Identifiants
pubmed: 33049604
pii: S0223-5234(20)30866-7
doi: 10.1016/j.ejmech.2020.112894
pii:
doi:
Substances chimiques
1-O-hexadecyl-2-O-methylglycero-3-lactose
0
Fluorescent Dyes
0
Glycolipids
0
KCNN3 protein, human
0
Potassium Channel Blockers
0
Pyrenes
0
Small-Conductance Calcium-Activated Potassium Channels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112894Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.